Brooke Bernhardt
Overview
Explore the profile of Brooke Bernhardt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
33
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heldrup J, Bleyer A, Ramsey L, Schaff L, Bernhardt B, Schwartz S, et al.
Cancer Chemother Pharmacol
. 2025 Mar;
95(1):41.
PMID: 40075030
Purpose: Folinic acid (FA) rescue protocols to counter the adverse effects of high-dose methotrexate (HDMTX) vary widely, and the risk of over-rescue and potential adverse effects of excessive FA (e.g.,...
2.
Rodriguez Torres C, Wicker N, Puccini de Castro V, Stefinko M, Bennett D, Bernhardt B, et al.
Dev Biol
. 2024 Aug;
516:183-195.
PMID: 39173814
Fibroblast Growth Factors and their receptors (FGFRs) comprise a cell signaling module that can stimulate signaling by Ras and the kinases Raf, MEK, and ERK to regulate animal development and...
3.
Holle L, Bilse T, Alabelewe R, Kintzel P, Kandemir E, Tan C, et al.
J Oncol Pharm Pract
. 2021 May;
27(4):785-801.
PMID: 34024179
The Oncology Pharmacy Team (OPT), consisting of specialty-trained pharmacists and/or pharmacy technicians, is an integral component of the multidisciplinary healthcare team (MHT) involved with all aspects of cancer patient care....
4.
Unguru Y, Fernandez C, Bernhardt B, Berg S, Pyke-Grimm K, Woodman C, et al.
J Natl Cancer Inst
. 2016 Jan;
108(6):djv392.
PMID: 26825103
Shortages of life-saving chemotherapy and supportive care agents for children with cancer are frequent. These shortages directly affect patients' lives, compromise both standard of care therapies and clinical research, and...
5.
Siden R, Kem R, Ostrenga A, Nicksy D, Bernhardt B, Bartholomew J
J Oncol Pharm Pract
. 2013 Jun;
20(3):217-24.
PMID: 23748870
Purpose: The increased use of oral chemotherapy for the treatment of cancer introduces new challenges for patients and caregivers. Among them are the ability to swallow oral solid dosage forms,...
6.
Parsons K, Bernhardt B, Strickland B
Ann Pharmacother
. 2013 Feb;
47(2):210-8.
PMID: 23386066
Objective: To systematically review clinical trials evaluating anti-disialoganglioside (GD2) antibodies in treating high-risk neuroblastoma in children. Data Sources: A literature search was conducted in PubMed/MEDLINE, International Pharmaceutical Abstracts, and Cumulative...